Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial to Evaluate the Efficacy and Safety of Spironolactone in Hemodialysis Patients

NCT01691053 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT01691053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01691053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial to Evaluate the Efficacy and Safety of Spironolactone in Hemodialysis Patients
Lead sponsor
Wuerzburg University Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2012
Completion date
March 28, 2018
Enrollment
118 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease / hemodialysis